
Eletriptan Hydrobromide 1-hydrate is a selective serotonin receptor agonist used to study the treatment of acute migraine. Researchers utilize this API for its high lipophilicity and potent inhibition of neuropeptide release.
In the field of headache medicine research, the selective activation of serotonin receptors is a primary therapeutic mechanism. Specifically, Eletriptan Hydrobromide 1-hydrate functions as a potent agonist at $5-HT_{1B}$, $5-HT_{1D}$, and $5-HT_{1F}$ receptors. Additionally, researchers select this molecule for its superior lipophilicity, which facilitates enhanced penetration into the central nervous system. Therefore, whether you investigate the inhibition of calcitonin gene-related peptide (CGRP) release or study the constriction of dural blood vessels, this API delivers reliable pharmacological support across various laboratory conditions.
[Image representing the serotonergic receptor binding of triptans in the neurovascular junction]
Zyntex maintains a transparent production chain to ensure a precise analytical profile for every batch, focusing on the limitation of related substances and enantiomeric purity. Moreover, our quality control team verifies every lot for water content (1-hydrate ratio) and residual solvent levels to ensure the integrity of your pharmacokinetic data. For instance, we optimize the purity to support the development of novel fast-dissolving delivery systems. As a result, your lab receives a high-purity reagent for advanced studies into the attenuation of neurogenic inflammation and the stabilization of cerebral blood flow.
Modern clinical science relies on high-quality triptans to address the debilitating impact of migraine and cluster headaches. Because Eletriptan Hydrobromide 1-hydrate possesses a documented high affinity for receptors involved in the pain signaling pathway, it remains a primary focus for studies involving acute abortive therapy. Ultimately, Zyntex provides a dependable foundation for your next innovation in neuropharmacology and specialized pharmaceutical engineering.
This high-selectivity serotonin agonist is vital for the following research and production sectors:
Scientists use Eletriptan to study the molecular affinity and efficacy at specific 5-HT receptor subtypes.
Researchers include this API in protocols focused on the suppression of CGRP and Substance P release.
Biotechnicians utilize this molecule to study the selective vasoconstriction of intracranial vessels without affecting systemic blood pressure.
This compound serves as a core tool for engineering oral and intranasal dosage forms with optimized absorption profiles.
| Parameter | Specification Standard |
|---|---|
| Product Name | Eletriptan Hydrobromide 1-hydrate (CAS 177834-92-3) |
| Molecular Formula | C22H26N2O2S · HBr · H2O |
| Purity | Ph. Eur. / USP Grade (Min. 99%) |
| Appearance | White to pale orange crystalline powder |
| Water Content | 3.5% – 5.0% (Monohydrate) |
🔬 Scientific Data: For detailed binding constants, metabolic pathway data, and safety profiles, consult: PubChem Entry: Eletriptan Hydrobromide (External Link)